CIK 0001390478 · Non-accelerated filer<br>Smaller reporting company
SELLAS Life Sciences Group, Inc.
Sign in to watch- Ticker
- SLS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 6462005278
- Business address
- 7 TIMES SQUARE, SUITE 2503, NEW YORK, NY, 10036
- Former names
- GALENA BIOPHARMA, INC., Galena Biopharma, Inc., RXI PHARMACEUTICALS CORP
- 4/A Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 8-K Event Delisting notice
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 10-K Report Annual Report
- 8-K Event Material agreement · Executive or director change · Other events
- 424B5 Offering Prospectus
- 424B5 Offering Prospectus
- 8-K/A Event Exhibits
- 8-K Event Material agreement · Acquisition or sale completed · Executive or director change
- 8-K Event Material agreement · Exit or restructuring costs · Unregistered share sale · Executive or director change
- NT 10-K Other NT 10-K
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
Page 51 of 64 · 1,276 filings